Identification and diagnosis of Cushing’s syndrome (CS) have historically been difficult due to the lack of commercially available, CE-IVD-marked testing options. Traditionally, laboratories developed in-house LC-MS-MS methods for dexamethasone measurement to detect CS. However, these in-house methods lacked inter-laboratory harmonization and resulted in a high false-positive rate.
Join Federico Ponzetto, PhD, from the Department of Medical Sciences at the University of Turin to learn more about:
- The clinical applications of dexamethasone testing
- Diagnosis and epidemiology of CS
- The current and new workflow of the dexamethasone suppression test
- How Tecan’s Steroid Panel LC-MS-MS kit helps to reduce the false-positive rate and systematizes inter-laboratory results
- The automation potential of diagnostic workflows using equipment such as Freedom Evo® and Resolvex® A200
